Bellerophon Therapeutics (BLPH) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free BLPH Stock Alerts $0.06 +0.00 (+0.18%) (As of 12:31 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBellerophon Therapeutics (NASDAQ:BLPH) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - April 22 at 2:20 AMBellerophon Therapeutics, Inc. (BLPH)uk.finance.yahoo.com - February 25 at 7:44 AMBellerophon Therapeutics Inc (BLPH)investing.com - February 15 at 2:18 AMBellerophon Offers Series A Stock in Private Salemsn.com - January 31 at 8:34 PMHilco Streambank Seeks Offers to Acquire Patent Portfolio and Material Inventory of Biotherapeutics Company Bellerophonbenzinga.com - November 28 at 2:49 PMBellerophon Therapeutics Inc BLPHmorningstar.com - November 2 at 3:08 PMBLPH - Bellerophon Therapeutics, Inc.finance.yahoo.com - August 8 at 3:59 PMWhat's Happening With Bellerophon Therapeutics Stock Today?msn.com - July 25 at 11:09 PMWhy Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?investorplace.com - July 25 at 10:03 AMBellerophon Therapeutics (BLPH) Price Target Decreased by 92.23% to 2.04msn.com - July 6 at 12:36 PMThe Latest Analyst Ratings for Bellerophon Therapeuticsmarkets.businessinsider.com - June 6 at 5:34 PMIs Bellerophon Therapeutics (BLPH) Outperforming Other Medical Stocks This Year?finance.yahoo.com - June 6 at 12:34 PMLaidlaw & Co. Downgrades Bellerophon Therapeutics (BLPH)msn.com - June 6 at 7:33 AMHC Wainwright & Co. Maintains Bellerophon Therapeutics (BLPH) Buy Recommendationmsn.com - June 6 at 7:33 AMBellerophon Therapeutics Stock Nosedive: Here's Whymsn.com - June 5 at 9:33 PMWhy Is Bellerophon Therapeutics (BLPH) Stock Down 79% Today?msn.com - June 5 at 10:40 AMBellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Diseasefinance.yahoo.com - June 5 at 10:40 AMmarketbeat.com - June 5 at 6:57 AMLucy Scientific, Bioventus top healthcare gainers; Enveric, Elevation among losersmsn.com - May 19 at 11:00 AMHC Wainwright Brokers Increase Earnings Estimates for Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)marketbeat.com - May 19 at 7:49 AMBellerophon Therapeutics (NASDAQ:BLPH) delivers shareholders fantastic 978% return over 1 year, surging 18% in the last week alonefinance.yahoo.com - May 17 at 10:28 AMBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Resultsfinanznachrichten.de - May 16 at 9:38 AMBellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 15 at 7:59 PMBellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Diseasefinance.yahoo.com - May 11 at 8:41 AMBellerophon Therapeutics (BLPH) Outpaces Stock Market Gains: What You Should Knowfinance.yahoo.com - April 28 at 9:31 PMBellerophon (BLPH) to Report Q1 Earnings: What's in the Cards?finance.yahoo.com - April 24 at 5:13 PMBellerophon Therapeutics (BLPH) Dips More Than Broader Markets: What You Should Knowfinance.yahoo.com - April 19 at 8:56 PMBellerophon Therapeutics, Inc. (NASDAQ:BLPH) Short Interest Down 40.8% in Marchmarketbeat.com - April 16 at 4:56 AMBellerophon Therapeutics (BLPH) Stock Sinks As Market Gains: What You Should Knowmsn.com - April 13 at 7:45 PMHC Wainwright & Co. Reiterates Bellerophon Therapeutics (BLPH) Buy Recommendationmsn.com - April 4 at 7:06 PMH.C. Wainwright Reaffirms Their Buy Rating on Bellerophon (BLPH)markets.businessinsider.com - April 4 at 8:54 AMWhen Will Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Turn A Profit?finance.yahoo.com - April 3 at 1:10 PMBellerophon Therapeutics GAAP EPS of -$2.08 misses by $0.06seekingalpha.com - April 2 at 10:07 AMBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Resultsfinanznachrichten.de - March 31 at 5:29 PMBellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Resultsfinance.yahoo.com - March 31 at 9:18 AMBellerophon Therapeutics (BLPH) Is a Great Choice for 'Trend' Investors, Here's Whyfinance.yahoo.com - March 28 at 2:00 PMHere's Why Momentum in Bellerophon Therapeutics (BLPH) Should Keep goingfinance.yahoo.com - March 10 at 7:29 PMBellerophon to Buy Rival Firm’s Sharesbaystreet.ca - March 6 at 11:07 AMBellerophon Therapeutics Surges 30% On Share Subscription Agreement With An Institutional Investormarkets.businessinsider.com - March 6 at 11:07 AMBellerophon Therapeutics Announces $5 Million Registered Direct Offeringfinance.yahoo.com - March 6 at 11:07 AMBellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Diseasefinance.yahoo.com - February 9 at 9:51 AMBellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Diseasefinance.yahoo.com - January 18 at 5:43 PMHow Is The Market Feeling About Bellerophon Therapeutics?benzinga.com - January 6 at 2:45 PMShort Volatility Alert: Bellerophon Therapeuticsbenzinga.com - January 6 at 9:43 AMCompanies Like Bellerophon Therapeutics (NASDAQ:BLPH) Could Be Quite Riskyfinance.yahoo.com - January 6 at 9:43 AMBellerophon Therapeutics Shares Gained Over 200% Todayfinance.yahoo.com - January 5 at 1:01 PMBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Resultsfinanznachrichten.de - November 14 at 1:37 PMBellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 14 at 8:36 AMBellerophon (BLPH) Receives FDA Acceptance to Reduce Study Sizefinance.yahoo.com - September 28 at 5:15 PMWhy Are Bellerophon Shares Jumping Today?finance.yahoo.com - September 27 at 4:12 PM Get Bellerophon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide BLPH Media Mentions By Week BLPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLPH News Sentiment▼0.690.33▲Average Medical News Sentiment BLPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLPH Articles This Week▼20▲BLPH Articles Average Week Get Bellerophon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: China SXT Pharmaceuticals News Aditxt News Allarity Therapeutics News Evofem Biosciences News Evelo Biosciences News Neptune Wellness Solutions News SciSparc News Ampio Pharmaceuticals News Aptevo Therapeutics News Athersys News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLPH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellerophon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
